Transcriptomics

Dataset Information

0

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE113229 | GEO | 2018/11/01

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
| S-EPMC6277197 | biostudies-literature
Genomics Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]
2018-11-01 | GSE113228 | GEO
Transcriptomics Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]
2018-11-01 | GSE113227 | GEO
Genomics Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma
| PRJNA450475 | ENA
Genomics Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]
| PRJNA450466 | ENA
Genomics Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]
| PRJNA450476 | ENA
Other SUMO2 Inhibition Reverses Aberrant Epigenetic Rewiring Driven by Synovial Sarcoma Fusion Oncoproteins and Impairs Sarcomagenesis
2024-11-06 | GSE276074 | GEO
Transcriptomics Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer
2024-12-18 | GSE234472 | GEO
Transcriptomics Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features
2014-07-31 | E-GEOD-54188 | biostudies-arrayexpress
Genomics Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer
2015-11-01 | E-GEOD-70047 | biostudies-arrayexpress